Rtms for stimulant use disorders (stimulus)(CTN-0108). 04/01/2023 - 09/01/2024. N01DA-22-2253. Task order 75N95023F00002 (TO6).
Ended Awarded Last action
- Contract number
- 75N95023F00002
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $369,589
Award facts
- Opportunity
-
- 75N95023F0002 Solicitation number
- Contract value 100% obligated
- $369,589.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Original award | $369,589 |
About this award
This federal contract award to The Emmes Company LLC is for the RTMS FOR STIMULANT USE DISORDERS (STIMULUS)(CTN-0108) project, which is being funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The contract has a period of performance from April 1, 2023 to September 1, 2024, with a total ceiling value of $369,589.00. The contract is a Delivery Order under the NIDA Data, Statistics, and Clinical Trial Support Center program, and is a Cost Plus Fixed Fee type contract. This award does not have a set-aside designation. The Emmes Company LLC is a global clinical research organization that specializes in providing biostatistical, data management, and logistical support for clinical research initiatives, particularly for federal agencies like NIH. Emmes has extensive experience supporting various NIH institutes, including NIDA, through both contract and grant awards.
Quick answers
Who was awarded contract 75N95023F00002?
75N95023F00002 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on April 1, 2023.
How much is contract 75N95023F00002 worth?
The government has obligated $369,589 on 75N95023F00002.
Is contract 75N95023F00002 an order under another contract?
Yes. 75N95023F00002 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95023F00002 competed?
The extent of competition for 75N95023F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award